Smaller craft cannabis growers could be better positioned to offer higher-quality cannabis products than larger-scale operations.

Much has been made of the benefits of large-scale operations by major cannabis producers. The largest players in today’s cannabis industry love to talk about their massive facilities and their capacity for supplying national markets from coast to coast. In a quickly evolving legal cannabis industry, however, the future could hold a place for a very different (and much smaller) kind of cannabis producer. As the industry matures and cannabis consumers realize they are spoiled for choice, those with discerning tastes are expected to seek out quality wherever they can find it. Due to the logistical challenges facing large-scale cannabis operations, these consumers could look to smaller craft cannabis producers.

What is craft cannabis?

Craft cannabis can be defined as small-batch cannabis that is grown by smaller producers that use highly optimized growing techniques that are difficult to replicate at scale. Consumers expect a higher quality from craft cannabis products, as smaller operations enable optimal growing conditions, which in turn results in a superior product.

New 4Front Ventures logo

This INNspired Article is brought to you by:

4Front Ventures (CSE:FFNT, OTCQX:CNXXF) is well on its way to becoming a leading vertically integrated multi-state cannabis company specializing in boutique cultivation, extraction and manufacturing as well as brand development, distribution and retail.Send me an Investor Kit

Craft cannabis follows the craft brew model

Major cannabis companies like Aurora Cannabis (TSX:ACB,NYSE:ACB) and Canopy Growth (TSX:WEED,NYSE:CGC) have already emerged as titans in the legal cannabis industry, but the North American cannabis market remains in its early stages. Craft cannabis producers are expected to challenge major players in the North American cannabis market in the same way craft beer producers have begun to eat away at market share from majors like Heineken (OTCQX:HEINY) and Molson Coors (NYSE:TAP). While the overall beer market shrunk slightly in 2018, the craft segment of the market grew by nearly 4 percent.

The factors that make craft beer appealing to a significant subset of beer drinkers run parallel to the factors that will give craft cannabis producers their place in the market. Both craft beer and cannabis products are seen as unique, offering quality products that are not available through major brands. Most importantly, craft cannabis producers are capable of delivering a consistent, quality product their major competitors cannot achieve through large-scale cultivation methods.

Micro-production licenses

The expense and logistics associated with cannabis production often include prohibitively expensive licensing, making craft production difficult in some markets. To address this, a growing number of jurisdictions have set up separate licensing categories for micro-production. These licenses cost less while limiting the amount of grow space permitted. Some states like Oregon and Massachusetts have gone so far as to lower the regulatory burdens and reduce license fees for small-scale commercial cannabis production to ensure smaller producers have equal access to the market. These small-scale licensing schemes mirror the regulatory reforms of the 1970s that allowed craft beer production to thrive among the industry giants.

Craft cannabis advantage

The idea that small growers produce a higher-quality product isn’t merely a matter of perception. While large growers generally focus on maximizing yield, craft producers working in smaller facilities tend to focus on quality within their defined grow space. Craft cannabis producers are able to control every parameter that can influence the growth of the plant, ensuring a consistent quality far superior to large-scale greenhouse operations.

Trimming buds by hand rather than using automated trimming machinery, for example, helps to preserve trichomes, but this method is impractical for mass growing operations. Ultimately, craft producers can use their size to their advantage by producing a better looking, tasting and smelling bud that will be more appealing to the consumer than the product offered by large-scale growers.

The major cannabis producers have thus far largely focused on scaling up, building massive grow spaces that allow them to produce cannabis at an incredible scale. This approach does, however, create challenges that often lead to compromises on quality. Large-scale grow spaces are at greater risk from insects and other pests, occasionally leading to a reliance on pesticides or product irradiation to control fungus. Small growers, on the other hand, are able to take more active measures, such as the use of organic pesticides, which are effective but labor intensive.

An evolving cannabis market

Today we’re witnessing the very early stages of the legal recreational cannabis market. As more jurisdictions open up new markets, companies are rushing to produce as much cannabis as possible. While this has been an effective strategy for a new industry, developing consumer preferences could change market dynamics. As new products hit the market and establish consumer preferences, it’s likely that the market could see a sizable contingent of cannabis buyers who are willing to pay a few more dollars per gram for a high-end experience. In general, large-scale cannabis producers are expected to compete below $1 per gram, while craft producers should be able to sell their product for well above $1 per gram. As we’ve seen in the beer and wine markets in recent years, local craft cannabis could rise in market share.

In the Canadian market, we have already seen a few examples of smaller craft growers making a name for themselves. Craft cannabis companies like Broken Coast Cannabis, Supreme Cannabis Company (TSX:FIRE) and Tantalus Labs have all become some of the most talked about brands in the industry while producing small batches, selling at comparatively high price points due to the tangible differences in quality.

4Front Ventures (CSE:FFNT,OTCQX:CNXXF) formerly known as Cannex Capital Holdings, is building a vertically integrated network of locally focused boutique brands, providing craft producers under the company’s umbrella with strong operations and experienced management while retaining craft growing methods and brands. The company has firmly established this model in its native Washington State with popular local brands like Northwest Cannabis Solutions. Cannex is now in the process of expanding into the emerging legal cannabis states of Illinois, Maryland, Massachusetts and Pennsylvania. From the company’s point of view, localized boutique branding of small-scale craft cannabis production could be the difference maker for successful cannabis brands.

Takeaway

Craft cannabis producers are uniquely equipped to provide the extra attention to detail in their growing practices, creating a premium bud that looks, tastes and smells better while carrying greater potency than the competition. As major cannabis producers race to battle over scale, craft cannabis producers have a unique opportunity to establish brand loyalty in discerning customers.


This INNSpired article is sponsored by 4Front Ventures (CSE:FFNT,OTCQX:CNXXF). This INNSpired article provides information which was sourced by the Investing News Network (INN) and approved by 4Front Ventures in order to help investors learn more about the company. 4Front Ventures is a client of INN. The company’s campaign fees pay for INN to create and update this INNSpired article.

This INNSpired article was written according to INN editorial standards to educate investors.

INN does not provide investment advice and the information on this profile should not be considered a recommendation to buy or sell any security. INN does not endorse or recommend the business, products, services or securities of any company profiled.

The information contained here is for information purposes only and is not to be construed as an offer or solicitation for the sale or purchase of securities. Readers should conduct their own research for all information publicly available concerning the company. Prior to making any investment decision, it is recommended that readers consult directly with 4Front Ventures and seek advice from a qualified investment advisor.

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less